|
29 Aug 2025 |
Metropolis Healthcare
|
Consensus Share Price Target
|
2187.40 |
2144.53 |
- |
-1.96 |
buy
|
|
|
|
|
18 May 2023
|
Metropolis Healthcare
|
Edelweiss
|
2187.40
|
1670.00
|
1241.30
(76.22%)
|
Target met |
Buy
|
|
|
Network expansion to drive growth
|
|
17 Feb 2023
|
Metropolis Healthcare
|
ICICI Securities Limited
|
2187.40
|
1933.00
|
1348.00
(62.27%)
|
|
Buy
|
|
|
Metropolis Healthcare’s (Metropolis) reported Q3FY23 performance was a mixed bag. Revenue declined 2.6% YoY (-5% QoQ) at Rs2.9bn (I-Sec: Rs2.8bn). Excluding Hi-Tech and government contract revenues, non-covid revenue grew ~13% YoY (+1,000bps from volume growth and +300bps from higher realisations).
|
|
10 Nov 2022
|
Metropolis Healthcare
|
ICICI Securities Limited
|
2187.40
|
1926.00
|
1621.05
(34.94%)
|
|
Buy
|
|
|
Metropolis Healthcare’s (Metropolis) reported Q2FY23 performance was broadly in line with our estimates. Revenue remained flat YoY (+7.3% QoQ) at Rs3bn (I- Sec: Rs3.1bn) on a high base which had benefited from covid-related business.
|
|
12 Aug 2022
|
Metropolis Healthcare
|
Edelweiss
|
2187.40
|
1965.00
|
1483.00
(47.50%)
|
|
Buy
|
|
|
Healthy performance in core business amid margin pressure
|
|
12 Aug 2022
|
Metropolis Healthcare
|
ICICI Securities Limited
|
2187.40
|
2013.00
|
1493.45
(46.47%)
|
|
Buy
|
|
|
Metropolis Healthcare’s (Metropolis) reported Q1FY23 performance was broadly in line with our estimates.
|
|
26 May 2022
|
Metropolis Healthcare
|
Edelweiss
|
2187.40
|
2402.00
|
1665.90
(31.30%)
|
|
Buy
|
|
|
Earnings miss estimates while margins dip
|
|
14 Feb 2022
|
Metropolis Healthcare
|
Edelweiss
|
2187.40
|
3400.00
|
2051.30
(6.63%)
|
|
Buy
|
|
|
Missed estimates, margin contraction with lower realisations
|
|
24 Dec 2021
|
Metropolis Healthcare
|
Edelweiss
|
2187.40
|
3639.00
|
3278.20
(-33.27%)
|
|
Buy
|
|
|
Metropolis Healthcare is one of the largest diagnostic chains in western India.
|
|
12 Nov 2021
|
Metropolis Healthcare
|
Edelweiss
|
2187.40
|
3753.00
|
3094.55
(-29.31%)
|
|
Buy
|
|
|
Marginally miss estimates, healthy margin continue
|
|
13 Sep 2021
|
Metropolis Healthcare
|
Edelweiss
|
2187.40
|
3356.00
|
3077.45
(-28.92%)
|
Target met |
Buy
|
|
|
Healthy expansion plan; major beneficiary of sector consolidation
|